Recall Alert: Injection Neocobal (Mecobalamin) B# S-2214 By M/s Pulse Pharma Lahore, Pakistan
Latest developments, a significant Recall alert of an important medication has been formally announced by the Government authorities after the DTL Faisalabad (WHO Prequalified) test report no. TRA-01-68030399/DTL dated 24-12-2024, wherein Injection Neocobal (Mecobalamin) B# S-2214 by M/s Pulse Pharma Lahore Pakistan was declared as Adulterated and of Sub-standard quality.
This post aims to furnish general public with critical information regarding this alert, including its consequences for both patients and healthcare professionals, as well as the necessary actions that one should take if anyone finds himself affected by this situation. It is imperative to stay informed in order to safeguard health and overall well-being of society at large.
This Recall Alert has been initiated due to presence of Cyanocobalamin other than Mecobalamin against the labelled claim of the said injection. This product Injection Neocobal (Mecobalamin) B# S-2214 by M/s Pulse Pharma Lahore Pakistan in retail sector. The provincial Inspector Tehsil and Town Faisalabad, having sufficient reasons that he believed, took the sample and sent it Drugs Testing Laboratory Faisalabad, earlier mentioned.
Risk Associated with use of substandard or adulterated Mecobalamin: when substandard or adulterated Mecobalamin injections are administered, patients can experience detrimental health consequences, including:
- Reduced effectiveness: Fake Mecobalamin injections may contain a small proportion of active ingredient or no active ingredient at all hence they cannot heal the intended medical condition.
- Increased risk of adverse reactions: Some of the dangerous substances or toxic precursors may be introduced at the time of using the Adulterated Mecobalamin injections which may affect the patients.
- Disruption of Vitamin B12 metabolism: Since the anemic tablets are just sweeteners mixed with contaminated or substandard Mecobalamin injections, it would distort the body Vitamin B12 balance causing anemia, neurological disorders among other associated ill health effects.
- Compromised treatment outcomes: Patients who are administered with poor quality or counterfeit Mecobalamin injections risk to worsen the overall progress of the disease and take longer time to recover hence; spend more money on their treatment bills.
- Loss of faith in medical professionals and institutions: Unscrupulous manufacture or purchase of high risk and cheap Mecobalamin injections can create distrust from patients from healthcare givers and facilities thus compromising the overall administration of quality and safe treatment regimes.
Action initiated: – In the Instant case the manufacturer has been directed to immediately recall the defected batch(s) of mentioned products from the market. All pharmacists and chemist working at distributions and pharmacies are also advised to immediately check their stocks and stop supplying this batch of product. Besides, authorities also directed the retailers/pharmacies/distributors to identify customers, and notify them at once, about the product alert of this product. Intimation to your customers may be enhanced by including a copy of alert notification through email/sms/copy or any other means.
The officials, further directed the corner concerned, that the remaining stock should be quarantined and returned to the supplier/ company under intimation to regulatory authorities. Moreover, Regulatory field force of DRAP and Provincial Regulatory authorities/Departments have also been informed regarding the subject matter of Injection Neocobal (Mecobalamin) B# S-2214 by M/s Pulse Pharma Lahore Pakistan. Likewise, it also has been directed to field force to increase vigilance within the supply chains of institutions/pharmacies/healthcare facilities that are likely to be affected by this affected batch of product. Supplementary to this, an advice for consumers / general public was also issued stating therein, consumers should stop using this Injection Neocobal (Mecobalamin) B# S-2214 by M/s Pulse Pharma Lahore Pakistan.
Conclusion
The recent alert concerning spurious drug associated with Injection Neocobal (Mecobalamin) B# S-2214 by M/s Pulse Pharma Lahore Pakistan, emphasizes the importance of vigilance in managing medications, both among healthcare professionals who prescribe them and patients who utilize them! Always prioritize staying informed about potential dangers linked with prescribed medications; possessing such knowledge can indeed be life-saving.